Globus Medical (GMED) Competitors $57.56 +0.95 (+1.68%) Closing price 07/17/2025 03:59 PM EasternExtended Trading$57.60 +0.04 (+0.07%) As of 07/17/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GMED vs. STE, PODD, BAX, HOLX, MASI, TFX, ITGR, ATEC, ATRC, and IARTShould you be buying Globus Medical stock or one of its competitors? The main competitors of Globus Medical include STERIS (STE), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Masimo (MASI), Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "health care equipment" industry. Globus Medical vs. Its Competitors STERIS Insulet Baxter International Hologic Masimo Teleflex Integer Alphatec AtriCure Integra LifeSciences Globus Medical (NYSE:GMED) and STERIS (NYSE:STE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment. Is GMED or STE more profitable? STERIS has a net margin of 11.26% compared to Globus Medical's net margin of 7.39%. STERIS's return on equity of 14.21% beat Globus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Globus Medical7.39% 10.52% 8.56% STERIS 11.26%14.21%9.13% Do analysts prefer GMED or STE? Globus Medical currently has a consensus target price of $91.09, indicating a potential upside of 58.25%. STERIS has a consensus target price of $266.50, indicating a potential upside of 18.83%. Given Globus Medical's higher probable upside, analysts clearly believe Globus Medical is more favorable than STERIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Globus Medical 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62STERIS 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media refer more to GMED or STE? In the previous week, STERIS had 9 more articles in the media than Globus Medical. MarketBeat recorded 24 mentions for STERIS and 15 mentions for Globus Medical. STERIS's average media sentiment score of 1.04 beat Globus Medical's score of 0.85 indicating that STERIS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STERIS 13 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, GMED or STE? STERIS has higher revenue and earnings than Globus Medical. STERIS is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobus Medical$2.52B3.09$102.98M$1.3442.96STERIS$5.46B4.04$614.64M$6.2036.17 Do institutionals and insiders have more ownership in GMED or STE? 95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 94.7% of STERIS shares are owned by institutional investors. 18.5% of Globus Medical shares are owned by insiders. Comparatively, 1.1% of STERIS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, GMED or STE? Globus Medical has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, STERIS has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. SummarySTERIS beats Globus Medical on 10 of the 16 factors compared between the two stocks. Get Globus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GMED vs. The Competition Export to ExcelMetricGlobus MedicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$7.66B$6.58B$5.56B$20.75BDividend YieldN/A1.28%3.80%3.67%P/E Ratio42.9625.4028.0527.62Price / Sales3.0963.96437.8959.14Price / Cash8.5020.4535.8422.13Price / Book1.894.688.254.66Net Income$102.98M$174.76M$3.24B$994.58M7 Day Performance0.83%2.05%1.45%0.00%1 Month Performance0.29%3.96%8.04%5.25%1 Year Performance-19.98%5.13%30.08%10.76% Globus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GMEDGlobus Medical4.9476 of 5 stars$57.56+1.7%$91.09+58.3%-21.0%$7.66B$2.52B42.965,300Analyst ForecastSTESTERIS4.8152 of 5 stars$233.09-1.9%$263.83+13.2%-1.9%$23.37B$5.46B37.6017,787Positive NewsAnalyst UpgradeAnalyst RevisionPODDInsulet4.4799 of 5 stars$300.70-0.1%$321.00+6.8%+43.4%$21.19B$2.07B54.083,900Analyst RevisionBAXBaxter International4.6145 of 5 stars$29.70-4.2%$36.14+21.7%-21.9%$15.91B$10.64B-27.0038,000Dividend AnnouncementAnalyst ForecastHOLXHologic4.7223 of 5 stars$64.37-0.6%$77.42+20.3%-18.8%$14.44B$4.03B27.167,063Positive NewsAnalyst ForecastMASIMasimo4.2332 of 5 stars$162.45-3.1%$191.60+17.9%+45.3%$9.09B$2.09B-17.725,600Positive NewsTFXTeleflex4.8435 of 5 stars$116.76-2.6%$164.63+41.0%-50.6%$5.30B$3.01B36.8314,100Analyst ForecastITGRInteger3.8901 of 5 stars$117.05-3.3%$145.00+23.9%-7.7%$4.22B$1.72B55.4711,000News CoveragePositive NewsUpcoming EarningsATECAlphatec4.1189 of 5 stars$10.93-0.5%$17.89+63.7%-9.5%$1.61B$611.56M-9.50700ATRCAtriCure3.1124 of 5 stars$31.54-0.7%$50.67+60.6%+18.7%$1.57B$465.31M-38.941,300IARTIntegra LifeSciences4.1214 of 5 stars$12.75-5.5%$18.63+46.1%-62.1%$1.05B$1.61B-33.554,396 Related Companies and Tools Related Companies STERIS Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Masimo Alternatives Teleflex Alternatives Integer Alternatives Alphatec Alternatives AtriCure Alternatives Integra LifeSciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GMED) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GMED Stock Alerts